“This is very personal to me.  I started ClearEdge out of concern for my kid’s health and frustration with the tools available to track his recovery post-injury.  As ClearEdge has developed, it’s turned into an effective tool for monitoring cognitive and balance-related issues.”

– Rich Uhlig, CEO and Founder, Quadrant Biosciences Inc.


ClearEdge Test was developed by Quadrant Biosciences Inc. Quadrant Biosciences is a collaborative effort led by company founder Richard Uhlig. ClearEdge provides clinicians a suite of tests and assessments to establish baselines and track changes in cognitive speed and reaction time and balance. The toolkit is comprised of separate tests for cognitive efficiency, balance assessment and symptoms tracking.


The ClearEdge Toolkit was developed as a suite of tests, containing ClearEdge Balance and ClearEdge DANA.

ClearEdge Balance was developed and validated in cooperation with SUNY Upstate  Medical Center’s Concussion Clinic and state-of-the-art Motion Analysis Lab located in the Institute for Human Performance (IHP) in Syracuse.

ClearEdge DANA was developed and validated by Anthrotronix Inc.

As part of the START-UP NY program, our headquarters is also strategically located within the IHP. This integral relationship with IHP allows us to maintain a close connection with the researchers and clinicians actively working in this space.

We Developed ClearEdge For:

  • Parents who are worried about their children’s health and afraid of the unseen consequences of brain development.
  • People of all ages who want to protect and prolong their quality of life and be on the alert for early onset of neurologic and balance-related disorders.
  • Healthcare providers who are frustrated with the lack of reliable, quantifiable tools for assessing balance and cognitive disorders, and are concerned about prematurely authorizing a patient’s return to activity.